-
Does Novo Nordisk and Novartis accelerate the peak period of cross-border pharmaceutical companies entering the acquisition market?
Recently, multinational pharmaceutical companies have launched another massive acquisition case, attracting global attention. On February 5th, Novo Nordisk announced that its controlling shareholder, ...